![]()
MIRA INFORM REPORT
|
Report Date : |
16.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
AFRI MEDICAL CO SAE |
|
|
|
|
Registered Office : |
13 El Obour Building, Salah Salem Road, Nasr City, P O Box 215,
Heliopolis, Cairo |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Year of Establishment : |
1983 |
|
|
|
|
Com. Reg. No.: |
224868, |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturers of medical requisites |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 750,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : AFRI MEDICAL CO SAE
Country of Origin :
Legal Form : Egyptian Joint Stock Company
Registration Date : 1983
Commercial Registration Number : 224868,
Chamber Licence Number : 0133
Issued Capital : £E 25,500,000
Paid up Capital : £E 25,500,000
Total Workforce : 450
Activities : Manufacturers of medical requisites.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 750,000
AFRI MEDICAL CO SAE
Building : 13 El Obour
Building
Street :
Area :
PO Box : 215,
Town :
Country :
Telephone : (20-2) 22606025
/ 22606015 / 22606045
Facsimile : (20-2)
22615600
Subject operates from a small suite of offices that are rented and
located in the Central Business Area of Cairo.
Branch Office (s)
Location Description
· 3C Industrial Zone Factory
premises
Sharkeya
10th of
Tel: (20-15)
361684 / 369428 / 369422
Fax: (20-15)
364104
Name Position
· Dr Nazih Ibrahim Ali El Aiady Chairman
· Dr Amin Helmy Hagar Managing
Director
· Dr Nariman Hassan Farid Director
· El Sayed Ahmed Mohsen Director
· Mohamed Nazih El Aiady Director
· Eman Nazih El Aiady Director
· Ahmed Essam Finance
Manager
· Mahmoud Labib Production
Manager
· Tarek El Hagary Sales
Manager
· Rami El Far Export
Manager
· Sherif Bahaa Public
Relations Manager
· Hafez Abd El Rehim Administration
Manager
· Rafik Qubtan IT
Manager
· Ahmed Hegazi Project
Manager
Date of
Establishment : 1983
Legal Form : Egyptian Joint
Stock Company
Commercial Reg.
No. : 224868,
Chamber Licence
No. : 0133
Issued Capital : £E 25,500,000
Paid up Capital : £E 25,500,000
· Dr Nazih Ibrahim Ali El Aiady 29.94%
· El Sayed Ahmed Mohsen 25.72%
· Dr Nariman Hassan Farid 25.20%
· Ahmed El Sayed Ahmed Mohsen 4.36%
· Mohamed Nazih El Aiady 3.78%
· Nazly El Sayed Ahmed Mohsen 3.53%
· Noha El Sayed Ahmed Mohsen 2.44%
· Eman Nazih El Aiady 1.93%
· Abeer Nazih Ibrahim Ali El Aiady 1.89%
· Tarek Ahmed Eissa Hassan 1.03%
· Dr Amin Helmy Hagar 0.18%
Activities: Engaged in the manufacture of medical requisites, including plasters,
bandages, blood transfusion
equipment,
solutions equipment, artery and vein joints, kidney dialysis and solution
packages
Subject is ISO 9001 and 9002 accredited.
Import Countries: Switzerland, Saudi Arabia, United States, Germany,
United Kingdom, Taiwan, Australia, India, Sudan, France, Belgium, Spain, South
Korea and Singapore
Export Countries:
Brand Names: AFRI MEDICAL
Operating Trend: Steady
Subject has a workforce of approximately 450 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pounds (£E)
Year
Ending 31/12/09: Year
Ending 31/12/10:
Total Sales £E
42,000,000 £E
56,969,897
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
·
Egyptian Gulf Bank
El
PO Box: 56
Tel: (20-2)
33606580 / 33606467
Fax: (20-2)
33420265 / 33606512
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.15 |
|
|
1 |
Rs.72.59 |
|
Euro |
1 |
Rs.62.95 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.